Filter results
You can narrow down the results using the filters
Health topics
Conditions and diseases
Year
Our work
9292 results
-
Coronavirus (COVID-19) common operating picture
A collection of weekly infographics that provide a traffic light report of the coronavirus (COVID-19) situation across Australia. -
Coronavirus (COVID-19) common operating picture – 27 January 2023
This infographic issued on 27 January 2023 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia. -
Life Saving Drugs Program resources – Gaucher disease
A collection of resources for health professionals to help people with Gaucher disease (type 1) access the following drugs under the Life Saving Drugs Program: imiglucerase (Cerezyme®), velaglucerase (VPRIV®), and taliglucerase (Elelyso®). -
Life Saving Drugs Program resources – Mucopolysaccharidosis type II (MPS II)
A collection of resources for health professionals to help people with mucopolysaccharidosis type II (MPS II) access idursulfase (Elaprase®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Pompe disease
A collection of resources for health professionals to help people with Pompe disease access alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations for consumers
This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations
This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations for consumers
This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – MPS II – Review summary and expert panel recommendations
This MPS II review considered idursulfase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations for consumers
This Gaucher disease review considered 3 enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health. -
Life Saving Drugs Program – Gaucher disease – Review summary and expert panel recommendations
This Gaucher disease review considered three enzyme replacement therapies (ERTs), imiglucerase, velaglucerase and taliglucerase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
My Aged Care – Service and Support Portal User Guide Part 1 – Administrator Functions
This user guide explains to administrators how to use the My Aged Care service and support portal. -
Government Provider Management System – Terms of use
This document outlines the terms of use for the Government Provider Management System (GPMS). The GPMS allows aged care service providers to see their Star Ratings. -
Budget October 2022–23
Fact sheets and other health, aged care and sport information from the October 2022–23 Budget. -
Residential aged care residents COVID-19 vaccination rates
The residential aged care residents COVID-19 vaccination rates provides data by facility across Australia and is updated every Wednesday. -
National Health and Medical Research Council – Projects funded
A list of National Health and Medical Research Council (NHMRC) projects and the committed funding. -
Evaluation of the COAG Section 19(2) Exemptions Initiative – Improving Access to Primary Care in Rural and Remote Areas Final Report
Evaluation of the COAG Section 19(2) Exemptions Initiative – Improving Access to Primary Care in Rural and Remote Areas Final Report -
COVID-19 response update for primary care – 16 February 2023
This webinar on 16 February is part of a series to update primary care on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions. -
COVID-19 response update for primary care – 2 February 2023
This webinar on 2 February is part of a series to update primary care on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions. -
Department of Health and Aged Care organisational chart
This chart shows the structure of the Department of Health and Aged Care, including our divisions, branches, statutory office holders and high priority taskforces. -
National Aged Care Advisory Council – Communiques
The National Aged Care Advisory Council list of monthly communiques. -
National Aged Care Advisory Council communique – December 2022
The meeting of the National Aged Care Advisory Council was held on 15 December 2022. -
Council of Elders communique – 8 and 9 December 2022
An update from the Council of Elders after their meeting on 8 and 9 December, 2022. -
Aged Care Council of Elders – Communiques
Communiques from the Council of Elders. -
AskMBS advisory – Established clinical relationship – Clarification of exemptions
Information and advice for general practitioners and other medical practitioners about the COVID-19 MBS telehealth ‘established relationship’ requirement, including a clarification of exemptions.